EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection

Peter P Reese, Sumit Mohan, Douglas E Schaubel, Rachel Forbes, Shikha Mehta, E Steve Woodle, Nianfu Song, Meghan E Sise, Raymond T Chung, Christine M Durand, Niraj Desai, Elizabeth C Verna und 13 weitere

Kidney International · 2025

DOI: 10.1016/j.kint.2025.07.026 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Kidney International, 2025. Verfasst von Peter P Reese und 24 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt Center for Transplant Science, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: peter.reese@vumc.org. Hauptthemen laut MEDLINE: Kidney Transplantation, Glomerulonephritis, Tissue Donors, Kidney. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, University of Miami.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Hepatitis C virus (HCV) infection is a leading cause of immune-complex mediated glomerulonephritis, specifically cryoglobulinemic and membranoproliferative glomerulonephritis, and has also been associated with non-glomerular kidney diseases. However, the prevalence of kidney disease among individuals with chronic HCV infection is unknown. Concerns about the quality of kidneys from deceased donors with HCV infection may lead centers to avoid transplanting these organs. METHODS: We assembled a multicenter histological database of deceased donor biopsies to compare the prevalence of glomerulonephritis and chronic disease pathology among 147 transplanted kidneys from HCV-RNA+ donors matched to 431 HCV-negative donors. RESULTS: The mean age was 40.3 versus 40.7 years for HCV-RNA+ versus HCV-negative donors, respectively. Expert pathology reviews showed that glomerular disease and isolated immune complex deposition were rare in both groups. The primary outcome of glomerulosclerosis, interstitial fibrosis with tubular atrophy, and/or vascular disease was non-inferior (15% margin) for HCV-RNA+ versus HCV-negative donor kidneys. Specifically, 61.2% versus 49% had under 5% glomerulosclerosis, 68% versus 58% had under 5% interstitial fibrosis with tubular atrophy, and 46% versus 25% had no vascular disease, for HCV-RNA+ versus HCV-negative donor kidneys, respectively. The recipients of kidney transplants from HCV-RNA+ donors and HCV-negative comparators both demonstrated good graft function and 12-month eGFR was not significantly different between groups (1.65 ml/min/1.73 m2 higher eGFR for HCV-RNA+ allograft recipients.) CONCLUSIONS: Our findings indicate that for HCV-RNA+ donor kidneys, glomerular disease was rare and chronic disease pathology was not more common than among HCV-negative kidneys, which may reassure clinicians to consider these organs for their patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGlomerulonephritisTissue DonorsKidneyHepatitis C, ChronicHepatitis CHumansMaleFemaleAdultPrevalenceMiddle AgedHepacivirusBiopsyRetrospective StudiesRNA, Viral

Stichwörter der Autor:innen

glomerulonephritishepatitis C virushistologykidney transplantation

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • Vanderbilt Center for Transplant Science, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: peter.reese@vumc.org.
  • Department of Medicine, Division of Nephrology, Vagelos College of Physicians & Surgeons, New York, New York, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, US…
  • Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Medicine, Division of Nephrology, University of Alabama, Birmingham, Alabama, USA.
  • Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA.

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • University of Miami
  • National Cancer Institute
  • NIH

Zitieren

APA

Reese, P. P., Mohan, S., Schaubel, D. E., Forbes, R., Mehta, S., Woodle, E. S., Song, N., Sise, M. E., Chung, R. T., Durand, C. M., Desai, N., Verna, E. C., Bittermann, T., Blanco, M., Shaffer, D., Concepcion, B. P., Alloway, R. R., Pagan, J. A., DuBay, D. A., …, & Goldberg, D. S. (2025). Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection. Kidney International. https://doi.org/10.1016/j.kint.2025.07.026

Vancouver

Reese PP, Mohan S, Schaubel DE, Forbes R, Mehta S, Woodle ES, et al. Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection. Kidney International. 2025. doi:10.1016/j.kint.2025.07.026

BibTeX
@article{Reese2025,
  author = {Reese, Peter P and Mohan, Sumit and Schaubel, Douglas E and Forbes, Rachel and Mehta, Shikha and Woodle, E Steve and Song, Nianfu and Sise, Meghan E and Chung, Raymond T and Durand, Christine M and Desai, Niraj and Verna, Elizabeth C and Bittermann, Therese and Blanco, Maria and Shaffer, David and Concepcion, Beatrice P and Alloway, Rita R and Pagan, Javier A and DuBay, Derek A and McGillicuddy, John W and Potluri, Vishnu and Huml, Anne M and Santoriello, Dominick and Stokes, M Barry and Goldberg, David S},
  title = {Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection},
  journal = {Kidney International},
  year = {2025},
  doi = {10.1016/j.kint.2025.07.026}
}
Kostenlos starten →